Peter Altman - 17 Aug 2023 Form 4/A - Amendment Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
17 Aug 2023
Transactions value $
$3,484
Form type
4/A - Amendment
Filing time
18 Aug 2023, 13:30:47 UTC
Date Of Original Report
17 Aug 2023
Previous filing
18 Aug 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $3.48K +4K +0.9% $0.87 447K 17 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $0.858 to $0.880 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.